Investing Profile

Mike Ross

InvestorVC
Managing Partner at SV Health Investors
svhealthinvestors.comSan Mateo, California
Photo of Mike Ross, Managing Partner at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
SV Health Investors Managing Partner
$100K - $5.0M
$1.5M
15
£200M
CompanyStageDateRound SizeTotal Raised
Therini Bio
Series AMay 2025$39M
Series AApr 2023$36M
SeedMay 2021$17M
SeedJul 2019$9M
$100M
Co-investors: Laurence Barker (SV Health Investors), Pascal Levensohn (Dolby Family Ventures), Jim Trenkle (Sanofi Ventures), Houman Ashrafian (SV Health Investors)
Eyebiotech
Series ANov 2023$65M
Series AFeb 2022$65M
$130M
Co-investors: Kate Bingham (SV Health Investors)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
Series ASep 2018$30M
$330M
Co-investors: Andrew Hack (Bain Capital Life Sciences), Jayson Punwani (Abingworth), Nancy Hong (San Diego Symphony), Jack Kenney (SV Health Investors), Peter Dudek (M Ventures (Merck))
Thesan Pharmaceuticals
Series BJan 2016
Series BFeb 2014$49M
$65M
Co-investors: Giovanni Ferrara
Avitide
Series CAug 2015$8M
Series AMar 2013$1M
$9M
Co-investors: Terry McGuire (Polaris Partners)
Arsanis
Series AFeb 2011$10M
$76M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Amy Schulman (Polaris Partners), Terry McGuire (Polaris Partners), Carl Gordon (OrbiMed Advisors)
Archemix
Series AAug 2002$52M
$100M
Co-investors: Peter Barrett (Atlas Venture)